• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 564

Protease from Bacillus licheniformis

Intended Use: For use in the production of partially or extensively hydrolyzed proteins for use in a variety of food and beverage products.
Basis: Scientific procedures
Notifier: Novozymes North America, Inc.
Notifier Address: 77 Perry Chapel Church Road, P.O. Box 576, Franklinton, NC 27525
Date of filing: Jan 2, 2015
GRAS Notice (releasable information): GRN 564 (in PDF) (2.3 MB)
Date of closure: Jul 7, 2015
FDA's Letter: FDA has no questions